Pricing
Prices are indicative MRP and may vary by pharmacy. Trend compares against the last recorded price.
All price changes →Save on this medicine
Same active ingredient — pay up to 73% less
These brands contain the same active ingredient (Sitagliptin). Strength and form may differ — confirm substitution with your doctor or pharmacist before switching.
Indications & Uses
Incrit is indicated for:
Dosage Reference
Reference Information Only
Dosages shown are general references from official sources. Always consult your doctor or pharmacist for personalized dosing.
Adults:
Recommended adult dose: 50 mg twice daily, or 100 mg once daily. Sitagliptin may be taken with or without food.
Side Effects
The most common side effects include headache, upper respiratory tract infection and nasopharyngitis. Hypoglycemia may occur when Sitadus is combined with a sulfonylurea or added on to insulin therapy.
Cautions & Contraindications
Warnings & Precautions
If pancreatitis is suspected, Sitadus should promptly be discontinued and appropriate management should be initiated.Use in Patients with Renal Insufficiency: Dosage adjustment is recommended in patients with moderate or severe renal insufficiency and in patients with ESRD requiring hemodialysis or peritoneal dialysis.Use with medications known to cause Hypoglycemia: When Sitadus is used in combination therapy dosage adjustment of sulfonylurea or insulin may be required to reduce the risk of hypoglycemia.Hypersensitivity Reactions: There have been post-marketing reports of serious hypersensitivity reactions in patients treated with Sitadus. These reactions include anaphylaxis, angioedema, and exfoliative skin conditions including Stevens-Johnson syndrome. If a hypersensitivity reaction is suspected, discontinue Sitadus, assess for other potential causes for the event, and institute alternative treatment for diabetes.
Contraindications
Contraindicated in patients with a history of serious hypersensitivity to sitagliptin, including reactions such as anaphylaxis or angioedema.